Evidence map›Paper›PMID 32094346›Full record

ArticleCell death & disease2020

Ferroptosis driven by radical oxidation of n-6 polyunsaturated fatty acids mediates acetaminophen-induced acute liver failure.

Naoya Yamada, Tadayoshi Karasawa, Hiroaki Kimura, Sachiko Watanabe, Takanori Komada, Ryo Kamata, Ariunaa Sampilvanjil, Junya Ito, Kiyotaka Nakagawa, Hiroshi Kuwata and 5 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 180 papers.

0numbers the graph read from it
0cells of the map it votes in
180citing papers in PubMed
12.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

180 citing papers in PubMed, 330 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Crosstalk between autophagy and ferroptosis in liver diseases (Review).International journal of molecular medicine · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Journal of Cancer · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Review

120 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Naoya YamadaDivision of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan.
Tadayoshi KarasawaDivision of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan.
Hiroaki KimuraDivision of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan.ORCID http://orcid.org/0000-0002-7441-0382
Sachiko WatanabeDivision of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan.
Takanori KomadaDivision of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan.ORCID http://orcid.org/0000-0003-3360-3185
Ryo KamataDivision of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan.
Ariunaa SampilvanjilDivision of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan.
Junya ItoFood and Biodynamic Chemistry Laboratory, Graduate School of Agricultural Science, Tohoku University, Sendai, Japan.
Kiyotaka NakagawaFood and Biodynamic Chemistry Laboratory, Graduate School of Agricultural Science, Tohoku University, Sendai, Japan.
Hiroshi KuwataDivision of Health Chemistry, Department of Healthcare and Regulatory Sciences, School of Pharmacy, Showa University, Tokyo, Japan.
Shuntaro HaraDivision of Health Chemistry, Department of Healthcare and Regulatory Sciences, School of Pharmacy, Showa University, Tokyo, Japan.
Koichi MizutaDepartment of Transplant Surgery, Saitama Children's Medical Center, Saitama, Japan.
Yasunaru SakumaDivision of Gastroenterological, General and Transplant Surgery, Department of Surgery, Jichi Medical University, Tochigi, Japan.
Naohiro SataDivision of Gastroenterological, General and Transplant Surgery, Department of Surgery, Jichi Medical University, Tochigi, Japan.
Masafumi TakahashiDivision of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan. masafumi2@jichi.ac.jp.ORCID http://orcid.org/0000-0003-2716-7532
Jichi Medical University · JPShowa University · JPTohoku University · JPSaitama Children's Medical Center · JP

Funding

Wellcome Trust
6 · The paper itself

Abstract

Acetaminophen (APAP) overdose is a common cause of drug-induced acute liver failure. Although hepatocyte cell death is considered to be the critical event in APAP-induced hepatotoxicity, the underlying mechanism remains unclear. Ferroptosis is a newly discovered type of cell death that is caused by a loss of cellular redox homeostasis. As glutathione (GSH) depletion triggers APAP-induced hepatotoxicity, we investigated the role of ferroptosis in a murine model of APAP-induced acute liver failure. APAP-induced hepatotoxicity (evaluated in terms of ALT, AST, and the histopathological score), lipid peroxidation (4-HNE and MDA), and upregulation of the ferroptosis maker PTGS2 mRNA were markedly prevented by the ferroptosis-specific inhibitor ferrostatin-1 (Fer-1). Fer-1 treatment also completely prevented mortality induced by high-dose APAP. Similarly, APAP-induced hepatotoxicity and lipid peroxidation were prevented by the iron chelator deferoxamine. Using mass spectrometry, we found that lipid peroxides derived from n-6 fatty acids, mainly arachidonic acid, were elevated by APAP, and that auto-oxidation is the predominant mechanism of APAP-derived lipid oxidation. APAP-induced hepatotoxicity was also prevented by genetic inhibition of acyl-CoA synthetase long-chain family member 4 or α-tocopherol supplementation. We found that ferroptosis is responsible for APAP-induced hepatocyte cell death. Our findings provide new insights into the mechanism of APAP-induced hepatotoxicity and suggest that ferroptosis is a potential therapeutic target for APAP-induced acute liver failure.

Indexed as

FerroptosisLipid PeroxidationAcetaminophenalpha-TocopherolAnimalsAntioxidantsCoenzyme A LigasesCyclohexylaminesCyclooxygenase 2DeferoxamineDisease Models, AnimalFatty Acids, Omega-6HepatocytesHumansIron Chelating AgentsLiverAcetaminophenAcsl4 protein, mousealpha-TocopherolAntioxidantsCoenzyme A LigasesCyclohexylaminesCyclooxygenase 2DeferoxamineFatty Acids, Omega-6ferrostatin-1Iron Chelating AgentsPhenylenediaminesPtgs2 protein, mouse

Identifiers

PMID32094346
PMCPMC7039960
OpenAlexW3008188366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.